The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2017 – 2019 Ranges: (58.66 – 88.98) (64.38 – 101.55) (70.20 – 98.79)
Weekly Chart
Daily Chart
5 Day Chart
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 120.63 | |
| 14 Day RSI at 70% | 106.00 | |
| 13-Week High | 98.79 | |
| 52-Week High | 98.79 | |
| 1-Month High | 98.79 | |
| 95.46 | 38.2% Retracement From 4 Week High | |
| 94.43 | 50% Retracement From 4 Week High/Low | |
| 94.29 | 14 Day RSI at 50% | |
| 93.41 | 38.2% Retracement From 4 Week Low | |
| 91.53 | 38.2% Retracement From 13 Week High | |
| Last | 90.75 | Last |
| 1-Month Low | 90.08 | |
| 89.29 | 50% Retracement From 13 Week High/Low | |
| 88.93 | 38.2% Retracement From 52 Week High | |
| 14 Day RSI at 30% | 87.29 | |
| 87.04 | 38.2% Retracement From 13 Week Low | |
| 85.88 | 50% Retracement From 52 Week High/Low | |
| 82.84 | 38.2% Retracement From 52 Week Low | |
| 13-Week Low | 79.78 | |
| 14 Day RSI at 20% | 78.55 | |
| 52-Week Low | 72.97 |
